Is Univastu India Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Univastu India Ltd (UNIVASTU.NS) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Univastu India Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Univastu India Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Univastu India Ltd?

Muslim investors may consider investing in Univastu India Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Univastu India Ltd classified as HALAL?

Musaffa determines the Shariah status of Univastu India Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Univastu India Ltd updated?

The Shariah compliance status of Univastu India Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Univastu India Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Univastu India Ltd?

You can check the latest Shariah compliance status of Univastu India Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Univastu India Ltd UNIVASTU.NS

₹72.05 ₹1.05 (1.48%) 1D

Last Updated: May 15, 12:00 AM·NSE

UNIVASTU.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: January 16, 2026

Report Source: 2026 2nd Quarter Report

Univastu India Ltd. Stock Analysis UNIVASTU.NS

India Industrials Nano Cap Report: Q2, 2026

Univastu India Ltd. engages in trading of construction materials. The company is headquartered in Pune, Maharashtra. The company went IPO on 2017-07-27. The firm provides integrated engineering, procurement, and construction services (EPC) for civil and structural construction and infrastructure sector projects. The firm is also engaged in trading of construction materials. Its trading products majorly include steel, cement and electrical materials. The company undertakes civil construction projects, such as metro stations, multipurpose halls, commercial structures, hospitals, cold storages, educational institutions, sports complexes, and mass housing projects. In addition, the Company engages in the water supply, drainage, road and bridge projects. The Company’s projects include Elevated Metro Station, Mumbai, Dr. Shyama Prasad Mukherjee Indoor Stadium, Jhansi Pustakalay, Net Zero Building, MSBTE Admin Building, Pune, 100 Bed Hospital, Pune, Indoor Sports Complex, Campal, Goa, Indoor Stadium at Sawalwada, Goa, MSIHMCT Building, Pune, and others.

Key Statistics of Univastu India Ltd (UNIVASTU.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹70.11₹72.50

Today's Open

₹71.00

Volume

54.06K

P/E Ratio (TTM)

24.43

52 Week Range

₹47.62₹104.88

Market Cap

2.51B

Avg. Volume

134.44K

Dividend Yield

Financial Metrics & Statements of Univastu India Ltd (UNIVASTU.NS)

FAQ's for Univastu India Ltd (UNIVASTU.NS)

According to Musaffa’s Shariah screening methodology, Univastu India Ltd (UNIVASTU.NS) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.